Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 349.9 M370.7 M357.4 M365.9 M 1.44 B Research & development ———— — Operating income -25.9 M197.6 M85.2 M-5 M 251.9 M Non-Operating Income, Total ———— — Interest expense, net of interest capitalized 8 M10 M9.1 M8.2 M 35.3 M Non-Operating Income, excl. Interest Expenses ———— — Unusual income/expense ———— — Pretax income -33.9 M187.6 M76.1 M-13.2 M 216.6 M Equity in earnings ———— — Taxes -9.8 M48.3 M15.5 M-5.4 M 48.6 M Non-controlling/minority interest -100 K1 M400 K600 K 1.9 M After tax other income/expense ———— — Net income before discontinued operations -26.6 M139.3 M59.1 M-9 M 162.8 M Discontinued operations ———— — Net income -26.6 M139.3 M59.1 M-9 M 162.8 M Dilution adjustment 2.6 M1 M1.1 M600 K 5.3 M Preferred dividends 2.6 M1 M1.1 M600 K 5.3 M Diluted net income available to common stockholders -26.6 M139.3 M59.1 M-9 M 162.8 M Basic earnings per share (Basic EPS) -0.63.161.32-0.2 3.68 Diluted earnings per share (Diluted EPS) -0.63.141.31-0.19 3.66 Average basic shares outstanding 44.59 M44.37 M44.8 M44.83 M — Diluted shares outstanding 44.59 M44.57 M45.04 M45.08 M — EBITDA -29.2 M194.1 M81.9 M351.1 M 597.9 M EBIT -42.5 M163.9 M68 M295.1 M 484.5 M Cost of revenue 621.3 M966.2 M821 M688.8 M 3.1 B Other cost of goods sold 621.3 M966.2 M821 M688.8 M 3.1 B Depreciation & amortization (cash flow) 13.3 M30.2 M13.9 M56 M 113.4 M